Tatva Chintan Pharma ChemTATVA 
0.31%24h
Tatva Chintan Pharma Chem (TATVA) Stock Overview
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals. The company serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. It also exports its products to various countries, including the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa. The company was incorporated in 1996 and is headquartered in Vadodara, India.
TATVA Stock Information
Tatva Chintan Pharma Chem (TATVA) Price Chart
Tatva Chintan Pharma Chem Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $11.60 | N/A |
| Market Cap | $257.12M | N/A |
| Shares Outstanding | 22.17M | 3.10% |
| Employees | 608.00 | N/A |
| Shareholder Equity | 5.15B | 8.81% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | 0.57 | N/A |
| P/S Ratio | 5.12 | N/A |
| P/B Ratio | 0.05 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | 0.0011 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $50.18M | N/A |
| Earnings | $5.42M | N/A |
| EPS | 20.52 | N/A |
| Earnings Yield | 1.77 | N/A |
| Gross Margin | 0.4426 | N/A |
| Operating Margin | 0.1395 | N/A |
| Net income margin | 0.1081 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $90.16M | N/A |
| Total Debt | $20.30M | N/A |
| Cash on Hand | $3.44M | N/A |
| Debt to Equity | 0.0056 | 19.99% |
| Cash to Debt | 0.1697 | -68.11% |
| Current Ratio | $1.33 | -47.82% |
